Articles
Self-Association and Solubility Behaviors of a Novel Anticancer Agent, Brequinar Sodium

https://doi.org/10.1002/jps.2600780204Get rights and content

Abstract

To aid in the selection of appropriate excipients to formulate brequinar sodium [6-fluoro-2-(2′-fluoro-1,1′-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt; DuP 785], studies were initiated to characterize thoroughly its solubility behavior. The measured solubilities at RT (~23°C) agreed with the theoretical values in the pH range from 0.5 to 7.2, but became significantly greater than theoretical values at pH values above 7.2. This deviation was likely due to the vertical stacking-type self-association between brequinar molecules in water. The NMR and pH methods determined a critical association concentration of 15 mg/mL. Sodium salicylate, which has been proven to interfere with molecular self-association, reduced drug solubility from 116 to 10 mg/mL. But urea, another deaggregative agent, gave about a twofold increase rather than a decrease in solubility. Addition of sodium chloride caused a 226-fold decrease in solubility. The apparent solubility product did not remain constant but decreased as sodium chloride concentration increased, suggesting that the added salt decreased the degree of self-association between brequinar molecules. Among four surfactants examined (a bile salt with a rigid fused ring versus three ordinary surfactants with a flexible chain structure), only sodium cholate significantly increased the aqueous solubility of brequinar sodium.

References and Notes (49)

  • ThakkarA.L. et al.

    J. Pharm. Sci.

    (1970)
  • RavinL.J. et al.

    J. Pharm. Sci.

    (1975)
  • RosemanT.J. et al.

    J. Pharm. Sci.

    (1973)
  • RoweE.L.

    J. Pharm. Sci.

    (1979)
  • WarrenR.J. et al.

    J. Pharm. Sci.

    (1970)
  • ChangY. et al.

    J. Pharm. Sci.

    (1978)
  • AttwoodD. et al.

    Int. J. Pharm.

    (1984)
  • FlynnG.L. et al.

    J. Pharm. Sci.

    (1970)
  • OngJ.T.H. et al.

    J. Pharm. Sci.

    (1975)
  • OngJ.T.H. et al.

    J. Pharm. Sci.

    (1976)
  • AndersonB.D. et al.

    J. Pharm. Sci.

    (1985)
  • EneverR.P. et al.

    J. Pharm. Sci.

    (1979)
  • AndersonB.D. et al.

    J. Pharm. Sci.

    (1983)
  • MukerjeeP.

    J. Pharm. Sci.

    (1974)
  • YanJ.F. et al.

    J. Colloid Interface Sci.

    (1969)
  • TouitouE. et al.

    J. Pharm. Sci.

    (1986)
  • TouitouE. et al.

    J. Pharm. Sci.

    (1987)
  • SatoS. et al.

    J. Pharm. Sci.

    (1983)
  • BogardusJ.B. et al.

    J. Pharm. Sci.

    (1979)
  • MukerjeeP. et al.

    J. Pharm. Sci.

    (1976)
  • CardinalJ.R. et al.

    J. Pharm. Sci.

    (1978)
  • DexterD.L. et al.

    Cancer Res.

    (1985)
  • ChenS.-F. et al.

    Cancer Res.

    (1986)
  • ThyrumP.T. et al.

    Nature

    (1969)
  • Cited by (20)

    • Recent contributions of quinolines to antimalarial and anticancer drug discovery research

      2021, European Journal of Medicinal Chemistry
      Citation Excerpt :

      In addition, despite its lower cLogP value, derivative 270a does not show a significantly increased water solubility compared to brequinar. Nevertheless, the promising results regarding the pharmacokinetic evaluation of derivative 270a legitimizes further investigation of 270a in the future [290]. Based on the zinc-binding properties of 8-hydroxyquinolines, Chen et al. designed a set of 8-hydroxyquinolines as matrix metalloproteinase (MMP) inhibitors, more specifically inhibitors of MMP-2 and MMP-9.

    • Amphiphilic drug–additive systems in aqueous and organic solvent–water mixed media: A comprehensive account on physicochemical properties

      2020, Journal of Molecular Liquids
      Citation Excerpt :

      The action and mode of aggregation of drugs from detailed studies can help to comprehend the physicochemical properties of drug/drug–additives systems. Various classes of amphiphilic drugs namely phenothiazine family drugs [53–56] and analgesics [57], benzodiazepine [44,58,59], tranquilizers [60], peptides [39,47,48] and nonpeptides [47,48,61], antibiotics [47,62], tricyclic antidepressants [46,63–65], antihistamines [66,67], anticholinergics [34,66], local anesthetics [68–70], non-steroidal anti-inflammatory [70,71] and anticancer drugs [72,73] have been explored to understand their physicochemical properties in aqueous medium. These investigations have been focused on several prospects which make the area quite vast.

    • Synergistic interaction between anti-allergic drug and cationic/anionic surfactants–Experimental and theoretical analysis

      2020, Journal of Saudi Chemical Society
      Citation Excerpt :

      Some drugs are also self-associate and behave like a surfactant. Some example of amphiphilic drugs are antihistamines [6], anticholinergics [7], analgesic [8], phenothiazine [9–13], peptide [14], antibiotics, tricyclic antidepressant [15,16], β-blockers [17], local anesthetics [18,19], non-steroidal anti-inflammatory drugs [20] and anticancer drug [21]. The body of these drugs may be containing one aromatic nucleus or peptide nature.

    View all citing articles on Scopus
    View full text